Page 302 - Demo

Chapter 930038. Janse AJ, Gemke RJBJ, Uiterwaal CSPM, Van Der Tweel I, Kimpen JLL, Sinnema G. Quality of life: Patients and doctors don’t always agree: A meta-analysis. J Clin Epidemiol. 2004;57(7). 39. Lunsky Y, Bramston P. A preliminary study of perceived stress in adults with intellectual disabilities according to self-report and informant ratings. J Intellect Dev Disabil. 2006;31(1). 40. Morrow AM, Hayen A, Quine S, Scheinberg A, Craig JC. A comparison of doctors’, parents’ and children’s reports of health states and health-related quality of life in children with chronic conditions. Child Care Health Dev. 2012;38(2). 41. Maguire S, Davison J, McLaughlin M, Simms V, Bunting B. Exploring the psychometric properties of self-report instruments used to measure health-related quality of life and subjective wellbeing of adolescents with intellectual disabilities: A Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) systematic review. J Appl Res Intellect Disabil [Internet]. 2023 Apr 26; Available from: http://www.ncbi.nlm.nih.gov/pubmed/37101341.42. Davison J, Maguire S, McLaughlin M, Simms V. Involving adolescents with intellectual disability in the adaptation of self-reported subjective well-being measures: participatory research and methodological considerations. J Intellect Disabil Res. 2022;66(7). 43. Ingerski LM, Modi AC, Hood KK, Pai AL, Zeller M, Piazza-Waggoner C, et al. Health-Related Quality of Life Across Pediatric Chronic Conditions. J Pediatr. 2010;156(4). 44. van Os J, Verhagen S, Marsman A, Peeters F, Bak M, Marcelis M, et al. The experience sampling method as an mHealth tool to support self-monitoring, self-insight, and personalized health care in clinical practice. Depress Anxiety. 2017;34(6). 45. Kang S, Jones A, Shaffer RC, Erickson CA, Schmitt LM. Developing Improved Outcome Measures in FXS: Key Stakeholder Feedback. SSRN Electron J. 2023.46. Bijkerk CJ, De Wit NJ, Muris JWM, Jones RH, Knottnerus JA, Hoes AW. Outcome measures in irritable bowel syndrome: Comparison of psychometric and methodological characteristics. Am J Gastroenterol. 2003;98(1). 47. Both P, ten Holt L, Mous S, Patist J, Rietman A, Dieleman G, et al. Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood. Epilepsy Behav. 2018.48. Krueger DA, Wilfong AA, Mays M, Talley CM, Agricola K, Tudor C, et al. Long-term treatment of epilepsy with everolimus in tuberous sclerosis. Neurology. 2016;87(23). 49. Lee EH, Kwon O, Hahm KB, Kim WH, Kim J Il, Cheung DY, et al. Irritable bowel syndromespecific health-related quality of life instrument: Development and psychometric evaluation. Health Qual Life Outcomes. 2016;14(1). 50. Gibbons C, Porter I, Gonçalves-Bradley DC, Stoilov S, Ricci-Cabello I, Tsangaris E, et al. Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice. Vol. 2021, Cochrane Database of Systematic Reviews. 2021. 51. Gaasterland CMW, Van Der Weide MCJ, Roes KCB, Van Der Lee JH. Goal attainment scaling as an outcome measure in rare disease trials: A conceptual proposal for validation. BMC Med Res Methodol. 2019.52. Gaasterland CMW, Jansen-van der Weide MC, Vroom E, Leeson-Beevers K, Kaatee M, Kaczmarek R, et al. The POWER-tool: Recommendations for involving patient representatives in choosing relevant outcome measures during rare disease clinical trial design. Health Policy (New York). 2018.53. Mueller T, Jerrentrup A, Bauer MJ, Fritsch HW, Schaefer JR. Characteristics of patients contacting a center for undiagnosed and rare diseases. Orphanet J Rare Dis. 2016;11(1). 54. Anazi S, Maddirevula S, Faqeih E, Alsedairy H, Alzahrani F, Shamseldin HE, et al. Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yield. Mol Psychiatry. 2017;22(4). 55. Chiurazzi P, Pirozzi F. Advances in understanding - genetic basis of intellectual disability. F1000Research. 2016;5. 56. Maia N, Nabais Sá MJ, Melo-Pires M, de Brouwer APM, Jorge P. Intellectual disability genomics: current state, pitfalls and future challenges. Vol. 22, BMC Genomics. 2021. Annelieke Muller sHL.indd 300 14-11-2023 09:08